De Backer G - Search Results

1

Atherosclerotic cardiovascular diseases in Belgium: a cost-of-illness analysis.

Vlayen J, De Backer G, Peers J, Moldenaers I, Debruyne H, Simoens S. Vlayen J, et al. Among authors: de backer g. Cardiovasc Drugs Ther. 2008 Dec;22(6):487-94. doi: 10.1007/s10557-008-6128-5. Epub 2008 Sep 16. Cardiovasc Drugs Ther. 2008. PMID: 18792772

2

Epidemiology of risk factors for hypertension: implications for prevention and therapy.

Kornitzer M, Dramaix M, De Backer G. Kornitzer M, et al. Among authors: de backer g. Drugs. 1999 May;57(5):695-712. doi: 10.2165/00003495-199957050-00003. Drugs. 1999. PMID: 10353295 Review.

3

Prevalence, awareness, treatment and control of arterial hypertension in an elderly population in Belgium.

De Backer G, Myny K, De Henauw S, Doyen Z, Van Oyen H, Tafforeau J, Kornitzer M. De Backer G, et al. Among authors: de henauw s. J Hum Hypertens. 1998 Oct;12(10):701-6. doi: 10.1038/sj.jhh.1000695. J Hum Hypertens. 1998. PMID: 9819018

4

Misclassification of coronary heart disease in mortality statistics. Evidence from the WHO-MONICA Ghent-Charleroi Study in Belgium.

De Henauw S, de Smet P, Aelvoet W, Kornitzer M, De Backer G. De Henauw S, et al. Among authors: de backer g, de smet p. J Epidemiol Community Health. 1998 Aug;52(8):513-9. doi: 10.1136/jech.52.8.513. J Epidemiol Community Health. 1998. PMID: 9876363 Free PMC article.

5

Trends and regional differences in coronary risk factors in two areas in Belgium: final results from the MONICA Ghent-Charleroi Study.

De Henauw S, De Bacquer D, de Smet P, Kornitzer M, De Backer G. De Henauw S, et al. Among authors: de bacquer d, de backer g, de smet p. J Cardiovasc Risk. 2000 Oct;7(5):347-57. doi: 10.1177/204748730000700508. J Cardiovasc Risk. 2000. PMID: 11143765

6

Number of women needed in a prospective trial to prove potential cardiovascular benefit of hormone replacement therapy.

Depypere HT, Tummers P, De Bacquer D, De Backer G, Do M, Dhont M. Depypere HT, et al. Among authors: de bacquer d, de backer g. Climacteric. 2007 Jun;10(3):238-43. doi: 10.1080/13697130701344786. Climacteric. 2007. PMID: 17487650

7

Addition of a novel, protective family history category allows better profiling of cardiovascular risk and atherosclerotic burden in the general population. The Asklepios Study.

Van daele CM, De Meyer T, De Buyzere ML, Gillebert TC, Denil SL, Bekaert S, Chirinos JA, Segers P, De Backer GG, De Bacquer D, Rietzschel ER; Asklepios Investigators. Van daele CM, et al. Among authors: de bacquer d, de buyzere ml, de backer gg, de meyer t. PLoS One. 2013 May 2;8(5):e63185. doi: 10.1371/journal.pone.0063185. Print 2013. PLoS One. 2013. PMID: 23658806 Free PMC article.

8

Under-registration of melanoma in Belgium: an analysis.

Brochez L, Verhaeghe E, Bleyen L, Myny K, De Backer G, Naeyaert JM. Brochez L, et al. Among authors: de backer g. Melanoma Res. 1999 Aug;9(4):413-8. doi: 10.1097/00008390-199908000-00012. Melanoma Res. 1999. PMID: 10504062

9

Lifetime-risk prediction: a complicated business.

De Backer G, De Bacquer D. De Backer G, et al. Among authors: de bacquer d. Lancet. 1999 Jan 9;353(9147):82-3. doi: 10.1016/S0140-6736(98)00404-8. Lancet. 1999. PMID: 10023886 No abstract available.

10

[Recommendations for the prevention of cardiovascular diseases in clinical practice].

De Backer G, De Bacquer D, Brohet C, De Ceukelier S, Franck A, Krzentowsky G, Legat P, Pochet JM, Scheen A; Groupe de Travail Belge de Prévention des Maladies Cardiovasculaires. De Backer G, et al. Among authors: de bacquer d, de ceukelier s. J Pharm Belg. 2005;60(2):41-50. J Pharm Belg. 2005. PMID: 16035368 Review. French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

516 results

Search Page